Nestler, Tim, Dalvi, Priya, Haidl, Friederike, Wittersheim, Maike, von Brandenstein, Melanie, Paffenholz, Pia, Wagener-Ryczek, Svenja, Pfister, David, Koitzsch, Ulrike, Hellmich, Martin, Buettner, Reinhard, Odenthal, Margarete and Heidenreich, Axel (2022). Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours. Br. J. Cancer, 126 (6). S. 937 - 948. LONDON: SPRINGERNATURE. ISSN 1532-1827

Full text not available from this repository.

Abstract

Background Testicular germ cell tumours (TGCTs) have a high metastasis rate. However, the mechanisms related to their invasion, progression and metastasis are unclear. Therefore, we investigated gene expression changes that might be linked to metastasis in seminomatous testicular germ cell tumour (STGCT) patients. Methods Defined areas [invasive tumour front (TF) and tumour centre (TC)] of non-metastatic (with surveillance and recurrence-free follow-up >2 years) and metastatic STGCTs were collected separately using laser capture microdissection. The expression of 760 genes related to tumour progression and metastasis was analysed using nCounter technology and validated with quantitative real-time PCR and enzyme-linked immunosorbent assay. Results Distinct gene expression patterns were observed in metastatic and non-metastatic seminomas with respect to both the TF and TC. Comprehensive pathway analysis showed enrichment of genes related to tumour functions such as inflammation, angiogenesis and metabolism at the TF compared to the TC. Remarkably, prominent inflammatory and cancer-related pathways, such as interleukin-6 (IL-6) signalling, integrin signalling and nuclear factor-kappa B signalling, were significantly upregulated in the TF of metastatic vs non-metastatic tumours. Conclusions IL-6 signalling was the most significantly upregulated pathway in metastatic vs non-metastatic tumours and therefore could constitute a therapeutic target for future personalised therapy. In addition, this is the first study showing intra- and inter-tumour heterogeneity in STGCT.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Nestler, TimUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dalvi, PriyaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Haidl, FriederikeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wittersheim, MaikeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Brandenstein, MelanieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Paffenholz, PiaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wagener-Ryczek, SvenjaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pfister, DavidUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Koitzsch, UlrikeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hellmich, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Buettner, ReinhardUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Odenthal, MargareteUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Heidenreich, AxelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-669959
DOI: 10.1038/s41416-021-01621-5
Journal or Publication Title: Br. J. Cancer
Volume: 126
Number: 6
Page Range: S. 937 - 948
Date: 2022
Publisher: SPRINGERNATURE
Place of Publication: LONDON
ISSN: 1532-1827
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
STAT3 ACTIVATION; GENE-EXPRESSION; IL-6; INTERLEUKIN-6; HETEROGENEITY; MICROENVIRONMENT; CHEMORESISTANCE; PROMOTES; INTEGRIN; RECEPTORMultiple languages
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/66995

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item